Brain imaging study for first-episode psychosis treatment
Treatments studied
Part of Mental health clinical trials.
This study uses brain scans to find markers that can predict how well antipsychotic medications work in people having their first episode of psychosis. It aims to help doctors choose the right treatment earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a first episode of a psychotic disorder like schizophrenia, schizoaffective disorder, or bipolar disorder with psychosis.
- You are currently experiencing moderate or more severe symptoms, such as disorganized thinking, grandiosity, hallucinations, or unusual beliefs.
- You have taken antipsychotic medication for a total of 8 weeks or less in your lifetime.
- You are between 15 and 40 years old.
- You are able to understand and sign a consent form.
- You do not have any serious neurological or endocrine disorder, brain injury, or condition requiring psychotropic medication.
- You are not at significant risk of harming yourself or others, and you do not have any reason that would prevent an MRI scan (like a pacemaker) or pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people who have had psychosis for less than 4 years to understand how their symptoms change over time and how they respond to treatment. By using brain scans and other tests, researchers hope to find better ways to personalize care for early psychosis.
This study looks at tiny molecules called microRNAs in the blood of people having their first episode of schizophrenia. It aims to find markers that could help guide treatment choices.
This study looks at whether special body and brain markers can predict how a person’s symptoms change over two years after a first psychotic episode. It may also help doctors understand who responds better to treatment, so future care can be more personalized.
This trial looks at people having a first psychotic episode who have not yet taken anti-psychotic medicine. It aims to see whether an early support approach can help, before other treatments become necessary.
This study looks at people with early psychosis who are about to start a new antipsychotic medication. It uses brain scans to understand how these medications work. If you are starting a new antipsychotic or changing your dose, this trial may be for you.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
Hear when a new Psychosis; Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.